#Pharma Manufacturers in Uzbekistan

[tocura]

A pharmaceutical product company is not merely focused on developing and selling medications; it also plays a vital role in patient education and support. These companies provide valuable information about various health conditions, treatment options, and the proper use of medications. Through educational materials, websites, help lines, and patient support programs, they empower individuals to make informed decisions about their health. By fostering a sense of empowerment and offering support, pharmaceutical product companies contribute to improved patient adherence and overall health outcomes.

[meddroid]

Resistant to change: Meddroid Pharma

Addressing antimicrobial resistance requires more stringent regulation and enforcement to control industrial practices that contribute to this issue.

The challenges surrounding antimicrobial resistance are exacerbated by the intricate and opaque nature of pharmaceutical supply chains. The majority of antibiotics fall into the category of off-patent generics, functioning essentially as commodities manufactured in large quantities with narrow profit margins. Under these conditions, manufacturers face substantial pressure to cut costs throughout the entire production process, from sourcing ingredients to the final drug formulation.

The opacity of the supply chain introduces complications by Dr. Smith the director of Meddroid Pharma. There are numerous manufacturers worldwide, ranging from major multinational corporations to small and medium enterprises specializing in a limited product range for local markets. The regulatory landscape varies widely, with some plants operating in regions where stringent regulations are well enforced, while others are subject to less rigorous oversight. Investigations reveal significant disparities in standards, encompassing product quality, purity, stability, hygiene, waste management, and environmental protection.

These challenges are not exclusive to antibiotics, as recent incidents in The Gambia, Indonesia, and Uzbekistan involving contaminated cough syrups demonstrate. Although a substantial portion of the pharmaceutical industry adheres to high standards, a lingering segment of producers either lacks the capacity or consciously chooses not to comply.

While certain segments of the industry are making strides in addressing antimicrobial resistance through voluntary, industry-led initiatives like external certification through organizations such as the AMR Industry Alliance, this transparency and accountability apply only to firms willing to invest effort in such programs. In the absence of effective regulation and enforcement, there remains a persistent risk that less scrupulous or financially strained operators may prioritize cost-cutting measures, regardless of their potential implications for environmental and public health.

About Author

Dr. Med O’Smith completed their medical education at Brighton & Sussex Medical School UK, earning their Doctor of Medicine (MD) degree. He demonstrated excellence early on, graduating at the top of their class and receiving numerous academic accolades. This solid foundation paved the way for a successful medical career.

[tocurailac]

Emerging Trends in the Pharma Manufacturers in Uzbekistan

The pharma manufacturers in Uzbekistan has been experiencing significant growth and development in recent years. With a strong focus on improving healthcare infrastructure and attracting foreign investment, Uzbekistan has become an attractive destination for pharmaceutical manufacturers. This article explores the emerging trends in the pharmaceutical industry of Uzbekistan and highlights the opportunities for growth and investment.

Government Support and Regulatory Reforms: The Uzbekistani government has taken proactive measures to promote the growth of the pharmaceutical industry. It has implemented several regulatory reforms to streamline the registration and approval process for pharmaceutical products. These reforms aim to enhance transparency, reduce bureaucratic hurdles, and facilitate the entry of new players into the market. Additionally, the government offers various incentives and tax breaks to attract pharmaceutical manufacturers to invest in Uzbekistan.

Increasing Healthcare Expenditure: Uzbekistan has witnessed a steady increase in healthcare expenditure, reflecting the government's commitment to improving healthcare services. The rising expenditure indicates a growing demand for pharmaceutical products, creating significant opportunities for manufacturers. The increased focus on healthcare infrastructure development, including hospitals and clinics, further boosts the demand for pharmaceuticals in the country.

Growing Domestic Pharmaceutical Market: The domestic pharmaceutical market in Uzbekistan is expanding rapidly. The rising population, coupled with increased healthcare awareness and access, has led to a surge in demand for high-quality pharmaceutical products. This presents a favorable environment for pharmaceutical manufacturers to tap into the growing market and establish a strong presence. Local manufacturers, known as Pharma Manufacturers in Uzbekistan, are well-positioned to cater to the domestic demand and contribute to the industry's growth.

Collaboration and Technology Transfer: The Uzbekistani government encourages collaboration and technology transfer between local and foreign pharmaceutical manufacturers. This exchange of knowledge and expertise facilitates the development of advanced manufacturing processes, quality control systems, and innovative drug formulations. Foreign companies partnering with Pharma Manufacturers in Uzbekistan can leverage the local industry's capabilities and gain a competitive edge in the regional market.

Export Potential and Regional Market Access: Uzbekistan's strategic location provides a gateway to the broader Central Asian and Eurasian markets. With its proximity to countries like Kazakhstan, Kyrgyzstan, and Tajikistan, Uzbekistan offers easy access to a combined population of over 70 million people. Pharmaceutical manufacturers in Uzbekistan can explore export opportunities and establish themselves as key players in the regional market. The government's efforts to improve trade relations & establish free trade zones further enhance the export potential of the industry.

The pharmaceutical industry in Uzbekistan is witnessing promising growth and presents ample opportunities for both domestic and foreign pharmaceutical manufacturers. With strong government support, regulatory reforms, and a growing domestic market, the industry is poised for further expansion. Collaboration, technology transfer, and regional market access add to the attractiveness of investing in Uzbekistan's pharmaceutical sector. As Pharma Manufacturers in Uzbekistan continue to innovate and meet the rising healthcare demands, the industry's growth potential is expected to soar, making it a lucrative avenue for investors and stakeholders alike.

[journalsmente]

Plagued by overseas deaths, India's cough syrup exporters must now take govt mandated tests

The quality check of the cough syrups has been taken after India's image as the "pharmacy of the world" took a knock following the WHO alerts on contaminated cough syrups.

NEW DELHI: From June 1, all cough syrup exporters will have to undertake mandatory testing of their products at specified government laboratories before getting permission for the outbound shipments.

The direction comes after three alerts issued by the World Health Organisation (WHO), in seven months, on contaminated India-made cough syrups.

“The export of cough syrup shall be permitted to be exported subject to export samples being tested and production of a certificate of analysis issued by any of the laboratories, with effect from June 1, 2023,” the Directorate General of Foreign Trade (DGFT) said in a notification on Monday.

The earmarked central government labs include Indian Pharmacopoeia Commission, Regional Drug Testing Lab (RDTL — Chandigarh), Central Drugs Lab (CDL — Kolkata), Central Drug Testing Lab (CDTL — Chennai, Hyderabad, Mumbai), RDTL (Guwahati) and the NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited drug testing labs of State governments.

The quality check of the cough syrups has been taken after India’s image as the “pharmacy of the world” took a knock following the WHO alerts on contaminated cough syrups.

For this, the Ministry of Health and Family Welfare would partner with the state governments and the exporters.

Officials believe this measure would help re-emphasise India’s commitment to assuring the quality of various exported pharmaceutical products. They added that necessary steps are being taken to ensure the smooth implementation of this testing requirement.

India exported cough syrups worth $17.6 billion in 2022–23 against $17 billion in 2021–22.

India-made cough syrups were allegedly linked to the deaths of 70 children in the Gambia and 18 children in Uzbekistan last year.

In April, WHO again raised an alert over contaminated India-made cough syrup sold in the Marshall Islands and Micronesia. But it was not just cough syrups.

Earlier this year, an India-manufactured eye drop was linked to an outbreak of highly resistant bacterial infections in the U.S.

The Centers for Disease Control and Prevention (CDC), which is the national public health agency of the US, had linked the eye drops manufactured by Chennai-based pharma company Global Pharma Healthcare to the likelihood of a highly drug-resistant bacteria gaining a foothold in the U.S.

India is the largest provider of generic drugs globally, supplying over 50 per cent of the global demand for vaccines, about 40 per cent of generic demand in the US, and about 25 per cent of all medicine in the UK.

Globally, India ranks third in pharmaceutical production by volume and 14th by value.

The industry includes a network of 3,000 drug companies and about 10,500 manufacturing units. It facilitates the availability and supply of high-quality, affordable, accessible medicines worldwide.

Similarly, over 80 per cent of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical firms.

[fanofsports]

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Among the world’s biggest rug exporters, India is investigating the firm whose cough syrup has been linked to the deaths India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces. In a statement on Thursday,…

[mubashirnews]

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Among the world’s biggest rug exporters, India is investigating the firm whose cough syrup has been linked to the deaths India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces. In a statement on Thursday,…

[arun-pratap-singh]

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Among the world’s biggest rug exporters, India is investigating the firm whose cough syrup has been linked to the deaths India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces. In a statement on Thursday,…

[rnewspost]

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Among the world’s biggest rug exporters, India is investigating the firm whose cough syrup has been linked to the deaths India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces. In a statement on Thursday,…

[tocura]

Browse Tocura's wide range of supplements and vitamins to maintain your health across a wide span. Made with the latest formulations and attestation by aggressive quality control, our products can provide maximum care toward general well-being.

[thetopbestguide]

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Among the world’s biggest rug exporters, India is investigating the firm whose cough syrup has been linked to the deaths India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces. In a statement on Thursday,…

[ahnewsworld]

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Indian pharma under scrutiny again after 18 Uzbek child deaths | Health News

Among the world’s biggest rug exporters, India is investigating the firm whose cough syrup has been linked to the deaths India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces. In a statement on Thursday,…

[werindialive]

18 children died in Uzbekistan after taking an excessive amount of cough syrup manufactured in India

The Health Ministry of Uzbekistan on Tuesday said that over 18 children have died after they developed acute respiratory disease from consuming excessive doses of a cough syrup, Doc-1 Max, manufactured by Marion Biotech, an Indian firm.

The children consumed the cough syrup in high amounts. The cough syrup contained ethylene glycol, which shouldn’t be a part of the composition at all. The news a few days after a parliamentary panel in The Gambia found “unacceptable levels” of diethylene glycol and ethylene glycol in cough syrups that were manufactured in Haryana-based Maiden Pharma. The cough syrup was earlier found to be instigating kidney injuries in kids and led to the death of 63 children.

The Indian ministry has that they are updated on the death of the children in the country but did not comment.

“To date, 18 out of 21 children with acute respiratory disease have died as a result of taking Doc-1 Max syrup... It was found that deceased children took 2.5-5 ml of the drug at home for 2-7 days, 3-4 times a day, which exceeds the standard dose of the drug for children. All children were given the drug without a doctor’s prescription. Since the main component of the drug is paracetamol, Doc-1 Max syrup was incorrectly used as an anti-cold remedy on the recommendation of the pharmacy sellers and this was the reason for the deterioration of the condition of the patients… preliminary laboratory studies have shown that this series of Doc-1 Max syrup contains ethylene glycol. This substance is toxic and about 1-2 ml/kg of a 95% concentrated solution can cause serious changes in the patient’s health, such as vomiting, fainting, convulsions, cardiovascular problems, and acute kidney failure.”

When translated, the statement from the Uzbekistan Health Ministry read, “Tablets and syrups of the drug Doc-1 Max are withdrawn from sale in all pharmacies of the country in a prescribed manner.”

For more international news in Hindi, subscribe to our newsletter.

[linhgd9]

Global Calcium Iodate Market – Top Industry Segments Analyzed in Latest Research Report by MRS

Global Calcium Iodate Market (Revenue and Volume), Type, Application, End-User, and Regional Analysis, Import-Export Analysis, Industry Analysis, Premium Insights, Global Calcium Iodate Market Revenue and Analyses of Intellectual Property Attractiveness of the market, competitive landscape, traders/distributors, key buyers, and so on Forecasts for the years 2021-2026

The global Calcium Iodate market study offers an in-depth look at the market on both a global and regional scale. The report analysis includes historical data (from 2015 to 2020) as well as predicted data (2021 – 2026). The research contains a thorough examination of the factors influencing market growth. The study assesses the global Calcium Iodate market’s driving forces as well as shifting dynamics, which have been cited as a growth driver.

The Calcium Iodate market’s current and future trends, opportunities, and threats are also covered in the report. The global Calcium Iodate market is segmented into type, application, and end-user segments. The report contains a thorough qualitative and quantitative examination of these components. Some of the tools used to research the market include value chain analysis, Porter’s five forces model, SWOT analysis, and PESTLE analysis. The report study also includes a full analysis of raw material sourcing with significant suppliers, raw material price patterns, and an examination of the industrial chain.

Get Exclusive Sample Report + To Know the Impact of COVID-19 on this Industry: https://www.marketresearchstore.com/sample/calcium-iodate-market-785240

Shengdian S&T, Ajay-SQM, Sinyiml, Nanjing Goldenhighway, Tocean Iodine Products, Jindian Chemical Co. Ltd, Hanwei Chemical, Samrat Pharmachem Limited, Iofina, Calibre Chemicals Pvt. Ltd., Deepwater Chemcials, IodiTech is one of the top companies mentioned in the reports.

The competitive landscape of the top players competing in the global Calcium Iodate market is covered in this study. It contains information about the company’s history, business strategy, market share analysis, product portfolio, financial overview, gross margin, and current advancements. Furthermore, the research is organised to provide critical information on current and future Calcium Iodate market trends, organisational requirements, and industry advances. In addition, the comprehensive Calcium Iodate study assists prospective entrants in examining the industry’s upcoming opportunities. Investors will gain a good understanding of the major Calcium Iodate players as well as their future projections. The report also includes information on the company’s strategic advancements, such as product launches, promotional activities, and brand developments, as well as ventures, acquisitions, and mergers and consolidations.

Global Calcium Iodate market by type (customizable): Pharma Grade, Food Grade, Feed Grade

Global Calcium Iodate Market by Application (Customizable): Pharma, Food, Feed

Impact Analysis of COVID-19:

The impact of COVID on market growth and development is well illustrated in this research for a better understanding of the Calcium Iodate market based on financial and industrial analyses. The COVID-19 pandemic has impacted a variety of markets, including the worldwide Calcium Iodate market. The dominant companies in the worldwide Calcium Iodate market, on the other hand, are adamant about adopting new tactics and seeking new finance resources in order to overcome the rising barriers to market expansion.

Request Pre and Post COVID-19 Impact Analysis on Calcium Iodate: https://www.marketresearchstore.com/sample/calcium-iodate-market-785240

Segmentation of Market Size by Region and Country (Customizable):

• The United States of America (U.S., Canada) • Europe (Germany, France, the United Kingdom, Italy, Spain, and the rest of Europe) (Russia, Netherlands, Switzerland, Poland, Sweden, Belgium, Norway, Austria, Ireland, Denmark, etc.) • Asia Pacific (China, Japan, India, South Korea), Southeast Asia (Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, and other Southeast Asian countries), Rest of Asia Pacific (Australia, New Zealand, Bangladesh, Kazakhstan, Uzbekistan, etc.) • Latin America (Brazil, Mexico, and the rest of the continent) (Chile, Argentina, Colombia, Peru, etc.) • GCC Countries (Saudi Arabia, Kuwait, Oman, Qatar, Bahrain, United Arab Emirates), South Africa, Rest of Middle East Africa (Iran, Turkey, Israel, Egypt, Nigeria, Algeria, Morocco, Kenya, Tanzania, Ghana, Angola, etc.)

Inquire To Know Additional List of Market Players Included, Request Here:: https://www.marketresearchstore.com/inquiry/calcium-iodate-market-785240

The following are the report’s main points:

1) Market trends

2) A plan for technological advancement

3) Policies governing regulation

4) Examine patents

5) Analysis of value chains, Porter’s Five Forces Model, PESTLE, and SWOT

6) Invisible market competitors

7) Framework for competition

8) Analysis of competitive rankings

9) Evaluation of investment opportunities

10) Analysis of raw materials and marketing techniques

11) Analysis of the manufacturing cost structure

12) Distributors/traders and purchasers’ list

About Us

Market Research Store is a single destination for all types of industries, global, and regional reports. We feature large repository of latest industry reports and market statistics published by reputed private publishers and public organizations.Market Research Store is the comprehensive collection of market intelligence products and services available. Our vast database of reports enables our clients to benefit from expert insights on global industries, products, and market trends.

Our Research Specialists have thorough knowledge about offerings from different publishers and different reports on respective industries. Our enabled team will help you refine search parameters and get desired results at your fingertips. Apart from the published market research reports, we also provide customized study on any topic to meet the varied and niche requirements of our clients. Whether you are looking for new product trends, competitive analysis or study on existing or emerging markets, Market Research Store has best offerings and expertise to get the critical information for you. You can also choose the option to purchase full reports or sections from the report to match your specific requirements.

from NeighborWebSJ https://ift.tt/3wUOcTl via IFTTT

from WordPress https://ift.tt/3zmZFfI via IFTTT

[medsdeltasupplier]

Generic Tykerb 250mg Alternative Supplier Online | Indian Lapatinib Wholesale Price | Generic Lapatinib 拉帕替尼 Wholesaler

Lapatinib Tykerb Tablet - A Cure for Breast Cancer Medicine

Are you someone who is suffering from the issues of breast cancer? Are you unable to figure out that which is the best medicine for you? If yes, then you should probably look for the medicine Lapatinib. The medicine is one of the best known for getting over certain types of breast cancer, out of which the main is HER2-positive.

The medicine belongs to the antineoplastic-protein tyrosine inhibitor class action. The main task of the medicine is to stop the cancer-causing cells, or we can say the carcinogen cells to grow in the body. The medicine is sold under the brand name Tykerb, and the manufacturer of medicine in India is GSK Pharma. The amount of salt that every tablet of medicine carries is around 250 mg which is a huge amount but is required to control this serious form of cancer.

Generic #Tykerb Alternatives #Herduo, #Abnib, #combinib, #Herlapsa, #Hertab, #Lapahope, #Lapatem at lower cost available at MedsDelta supplier and distributor of quality afford products. Lapatinib 拉帕替尼 Tablet online without dealing with any hassle during your purchasing and payment process. MedsDelta offering Indian Lapatinib Tablet at wholesale price, Tykerb manufactured by GlaxoSmithKline (GSK) and marketed by Novartis. This medication is accessible as the brand-name tranquilize Tykerb. Contact us at +91-9971646666, Viber/Signal: +91-9971646666 for get detailed information about the Lapatinib Tablet Alternatives or Generic Tykerb from MedsDelta having Lapatinib (拉帕替尼) 250mg with delivery to countries more than 150 including Fiji, Laos, Kenya, Lebanon, Libya, Luxembourg, Peru, Uruguay, USA, Hong Kong, China, UK,Russia, Vietnam, Philippines etc.

Lapatinib 250mg Tablet Brands and Manufacturers in India

Herduo Lapatinib 250mg Tablet - Natco Pharma Ltd.

Hertab Lapatinib 250mg Tablet - Hetero Oncology

Tykerb Lapatinib 250mg Tablet - Novartis

Abnib Lapatinib 250mg Tablet - Abbott Laboratories

Combinib Lapatinib 250mg Tablet - Cipla Ltd

Herlapsa Lapatinib 250mg Tablet - Mylan Pharmaceuticals

Lapahope Lapatinib 250mg Tablet - Glenmark Pharmaceuticals

Lapatem Lapatinib 250mg Tablet - Emcure Pharmaceuticals

View all Lapatinib 250mg Tablet Brands and Manufactures

How to take Lapatinib 拉帕替尼 Tablet :

Take this pill by mouth 1 hour before or 1 hour after a meal, regularly once daily or as instructed by your doctor. You mustn't take this medicine more than once daily.

How to use the Indian Lapatinib Tablet?

There is a guideline that you should keep in mind when you are consuming the medicine Lapatinib. They are mentioned below in detail.

You should always take medicine with a glass full of water in its original form. If you try to change the form by biting, chewing, or hitting it, you will not get the medicine results.

The medicine needs to be consumed at a proper time gap from food. If consuming before food, then the time gap will be 1 hour, and if consuming after that, then the time gap should be a minimum of 2 hours.

The medicine should always be taken at the time that the physician fixes. You should better set the alarm for remembering.

Side effects of the Generic Lapatinib Tablet:

Your head may start paining with other small issues like dizziness, drowsiness and nausea also.

You may notice an upset stomach and diarrhoea.

Your skin may develop some rashes and can become severe.

Your limbs may show upswelling.

Where to Buy Original Lapatinib 拉帕替尼 Tablets at Wholesale Price :

MedsDelta is a well-known healthcare brand who delivers authentic medical products all over the world. We have a tie-up with world biggest pharmaceutical giants and drug manufacturers like Natco Pharma Limited, Cipla Ltd, Abbott, Sun Pharma, Dr. Reddy's, Hetero Healthcare, Glenmark, Intas, Ranbaxy, etc. We know the importance of medicines and make sure that you get it in time from one of the biggest suppliers of pharmaceuticals.

We supply all kinds of generic and branded drugs at wholesale price to pharmacies, hospitals, clinics and other healthcare providers to make sure that medicines are being provided to people in need. It's our goal to provide authentic and good quality medicines at affordable prices. We source, store, and supply a comprehensive range of medical products in the major therapeutic areas like Oncology, Hepatitis, HIV/AIDS, Arthritis and others. We deliver all over the world including nations like USA, UK, Cambodia, Philippines, China, Uzbekistan, Ukraine, Venezuela, Afghanistan and Vietnam among others.

Contact Us:

Mail: info@medsdelta.com

Call/WhatsApp: +91–9971646666,

Viber/Signal: +91-9971646666

WeChat or Skype: MedsDelta.

[maatrhealthcare]

Maatr Healthcare Private Limited is one of the most trusted pharmaceutical company that export their best quality pharmaceutical products to region like CIS Countries. 1. We provide best Quality Assurance Guaranteed pharmaceutical products 2. We provide best quality with good quantity at reasonable prices. 3. Best manufacturing machinery units. 4. Best packing facilities available 5. Competitive cost of products.

[passageoverseas]

Pharmaceutical Caps Manufactures, Exporters, Suppliers of UK , Canada, Japan, Indonesia, Malaysia, Germany, France, Italy, Spain, Greece. Switzerland, Netherlands, Poland, Croatia, Austria, Belgium, Ukraine, Sweden, Norway, Iceland, Malta, Czechia

We manufacturing, supplying, trading and exporting of Packaging Materials like Pharmaceuticals bottles manufacturers, Pharmaceuticals container exporters, Pharmaceuticals container suppliers, Pharmaceuticals containers, pharma containers, pharma bottle, pharmaceutical bottles, pharmaceutical containers, pharmaceutical glass bottles, pharmaceutical glass vials, hdpe bottles for pharmaceutical, plastic containers for pharmaceutical use, pharmaceutical plastic bottles, pharma plastic bottles, pharmaceutical plastic containers, pharma pet bottles, pharma glass bottles, hermetic container pharmacy, plastic medicine bottle manufacturers, pharma glass bottle manufacturers, pharmaceutical glass containers, plastic bottle for pharmaceutical use, pharmaceutical storage containers, pharmaceutical dropper bottles, pharmaceutical pill bottles, pharmaceutical grade plastic containers, pharma plastic bottle manufacturer, precis pharma containers, pharmaceutical spray bottles, pharmaceutical bottles wholesale, plastic medicine bottle suppliers, pharmaceutical pet bottles, 18 x 12 mm ROPP CAPS, 20 x 12 mm ROPP CAPS, 22 x 15 mm ROPP CAPS, 25 x 17 mm ROPP CAPS, 28 x 18 mm ROPP CAPS, 28 x 15.5 mm ROPP CAPS, 31.5 x 18 mm ROPP CAPS, 31.5 x 24 mm ROPP CAPS, 30 x 24 mm ROPP CAPS etc. Our continuing investments in equipment and personnel ensure the very highest quality of products and service.

Our Major Markets are Afghanistan, Albania, Algeria, Andorra, Angola, Anguilla, Antigua & Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus,  Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia & Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, China - Hong Kong / Macau, Colombia, Comoros, Congo, Congo Democratic Republic of (DRC), Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, French Guiana, Gabon,Gambia, Georgia, Germany, Ghana, Great Britain, Greece, Grenada, Guadeloupe,  Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Israel and the Occupied Territories, Italy, Ivory Coast (Cote d'Ivoire), Jamaica, Japan, Jordan, Kazakhstan, Kenya, Korea, Democratic Republic of (North Korea), Korea, Republic of (South Korea), Kosovo, Kuwait, Kyrgyz Republic (Kyrgyzstan), Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Moldova, Republic of, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar/Burma, Namibia, Nepal, New Zealand, Nicaragua, Niger, Nigeria, North Macedonia, Republic of, Norway, Oman, Pacific Islands, Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Reunion, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovak Republic (Slovakia), Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Netherlands, Timor Leste, Togo, Trinidad & Tobago, Tunisia, Turkey, Turkmenistan, Turks & Caicos Islands, Uganda, Ukraine, United Arab Emirates, United States of America (USA), Uruguay, Uzbekistan, Venezuela, Vietnam, Virgin Islands (UK), Virgin Islands (US), Yemen, Zambia, Zimbabwe etc.Please visit our website at http://passageoverseas.com/ for more information. With Best regards, Sunny Gupta Cell phone : + 91 7389715797 e mail: info@passageoverseas.com